FDA Approves Spinal Cord Stimulation (SCS) System for Diabetic Peripheral Neuropathy
On January 26, 2023, it was announced that the FDA (US Food and Drug Administration) had approved Abbott’s Proclaim XR spinal cord stimulation (SCS) system for treating painful diabetic peripheral neuropathy ...
Read more ...